Table 1 Morphology related to time periods

Adenocarcinoma (a)

8140/3

5,460 (92.0%)

5,972 (93.2%)

6,183 (92.4%)

6,001 (88.4%)

23,616 (91.5%)

Papillary serous cystadenocarcinoma (b)

8460/3

116 (2.0%)

150 (2.3%)

220 (3.3%)

332 (4.9%)

818 (3.2%)

Clear cell adenocarcinoma (b)

8310/3

84 (1.4%)

88 (1.4%)

102 (1.5%)

167 (2.5%)

441 (1.7%)

Serous cystadenocarcinoma (b)

8441/3

1 (0.02%)

3 (0.1%)

11 (0.2%)

168 (2.5%)

183 (0.7%)

Carcinoma, undifferentiated (b)

8020/3

37 (0.6%)

46 (0.7%)

40 (0.6%)

35 (0.5%)

158 (0.6%)

Adenosquamous carcinoma (a)

8560/3

57 (1.0%)

59 (0.9%)

30 (0.5%)

10 (0.2%)

156 (0.6%)

Papillary adenocarcinoma (a)

8260/3

80 (1.4%)

35 (0.6%)

18 (0.3%)

3 (0.04%)

136 (0.5%)

Mucinous adenocarcinoma (a)

8480/3

43 (0.7%)

14 (0.2%)

39 (0.6%)

20 (0.3%)

116 (0.5%)

Endometrioid adenocarcinoma (a)

8380/3

22 (0.4%)

14 (0.2%)

9 (0.1%)

19 (0.3%)

64 (0.3%)

Carcinoma (b)

8010/3

10 (0.2%)

10 (0.2%)

18 (0.3%)

17 (0.3%)

55 (0.2%)

Squamous cell carcinoma (b)

8070/3

6 (0.1%)

10 (0.16%)

9 (0.1%)

4 (0.1%)

29 (0.1%)

Adenocarcinoma with squamous metaplasia (a)

8570/3

13 (0.2%)

2 (0.03%)

7 (0.1%)

1 (0.01%)

23 (0.1%)

Neuroendocrine carcinoma (b)

8246/3

0 (0.0%)

0 (0.0%)

1 (0.01%)

7 (0.1%)

8 (0.03%)

Mucinous cystadenocarcinoma (a)

8470/3

1 (0.02%)

1 (0.02%)

0 (0.0%)

5 (0.1%)

7 (0.03%)

Small cell carcinoma (b)

8041/3

0 (0.0%)

1 (0.02%)

3 (0.04%)

1 (0.01%)

5 (0.02%)

Carcinoma, anaplastic (b)

8021/3

1 (0.02%)

0 (0.0%)

1 (0.01%)

1 (0.01%)

3 (0.01%)

Mesonephroma, malignant (c)

9110/3

2 (0.03%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

2 (0.01%)

Adenoid cystic carcinoma (c)

8200/3

0 (0.0%)

1 (0.02%)

0 (0.0%)

0 (0.0%)

1 (0.0%)

Cystadenocarcinoma (a)

8440/3

0 (0.0%)

0 (0.0%)

1 (0.01%)

0 (0.0%)

1 (0.0%)

Large cell carcinoma (c)

8012/3

0 (0.0%)

0 (0.0%)

1 (0.01%)

0 (0.0%)

1 (0.0%)

Transitional cell carcinoma (c)

8120/3

0 (0.0%)

0 (0.0%)

1 (0.01%)

0 (0.0%)

1 (0.0%)

Total

5,933 (100.0%)

6,406 (100.0%)

6,694 (100.0%)

6,791 (100.0%)

25,824 (100.0%)